Landmark Alzheimer's drug approval confounds research community

MeSH terms

• Alzheimer Disease / drug therapy*
• Alzheimer Disease / pathology
• Amyloid beta-Peptides / metabolism
• Antibodies, Monoclonal, Humanized / adverse effects
• Antibodies, Monoclonal, Humanized / pharmacology
• Antibodies, Monoclonal, Humanized / therapeutic use*
• Brain / drug effects
• Brain / pathology
• Clinical Trials, Phase III as Topic
• Cognition / drug effects
• Drug Approval / legislation & jurisprudence*
• Drug Industry
• Hope
• Humans
• Models, Biological
• Molecular Targeted Therapy
• Plaque, Amyloid / drug therapy
• Plaque, Amyloid / metabolism
• Plaque, Amyloid / pathology
• Reproducibility of Results
• Uncertainty*
• United States
• United States Food and Drug Administration / legislation & jurisprudence*
• tau Proteins / metabolism